A dually active anthrax vaccine that confers protection against both bacilli and toxins. - Wikidata - wikimedia - TriplyDB

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

http://www.wikidata.org/entity/Q35978682

about

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin Rabies virus glycoprotein as a carrier for anthrax protective antigen Anthrax vaccination strategies Monoclonal antibody therapies against anthrax IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.Identification of a second collagen-like glycoprotein produced by Bacillus anthracis and demonstration of associated spore-specific sugars.Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway.Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin.Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.Bacillus anthracis capsule activates caspase-1 and induces interleukin-1beta release from differentiated THP-1 and human monocyte-derived dendritic cells.Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis.Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.The poly-γ-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity.Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis.An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis Detoxified lethal toxin as a potential mucosal vaccine against anthrax.Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

P2860

Q24562788-09711C9D-6D60-473D-8B72-DF168F43BC96 Q24796044-BAEE05EC-2D8B-486D-BD49-B604E5B200F6 Q28391261-5DA0F63C-D20A-419B-8A00-3EF65283C70E Q28392248-7C68D179-198B-45F1-A10A-E8C9E0A0C229 Q28393072-EB9C8729-4DCF-4996-AC56-7FE2659B69C6 Q31116360-66B6CEB7-C142-4BAB-9A68-663C9DE1F5D6 Q33217514-DAA7E920-C679-4766-A3BD-7FFF06DC8F64 Q33224077-D8C9E48C-D583-4D9D-ACFE-7B524ACB8B2E Q33227409-0CF78073-1A39-4378-917D-9360BB5B90D0 Q33261310-C6C26AC2-E195-42E4-888B-5004CE79B44E Q33284583-2EF81AEA-6775-475D-87E9-EBC11F1E086F Q33360151-A243B724-BA5F-4509-B6BF-27E78BE9ABB7 Q33383858-91D676F7-18CD-4125-B5F4-4839C40268F1 Q33385362-FA7C0091-43F9-4EDF-A44F-455E78FBF545 Q33396429-0FAD606A-AC96-4838-9845-45A035D595F0 Q33505445-1616D5CF-7F0D-4EE9-B041-D26711DD0106 Q33557788-FA539C8A-E256-4B3D-8297-5D4600422D58 Q33739694-774A910E-542A-430C-A0C4-4403DAB0CF4F Q33778606-C3591E11-89DB-486F-9862-12662E9B349B Q33788263-9C94A29B-F616-4946-AD27-7400EF191B99 Q33883273-3B8DC375-5D4D-4733-8DB7-0FC6D00321C7 Q34490786-2E5F9546-F633-4379-BE78-BA952BC40367 Q34721071-1DB7693C-DC87-4CAE-A5CC-5D5A227781B7 Q34839450-195D1095-4346-4D46-BEBC-DEBC614A0C62 Q35052264-D2F1D647-AFE3-4E28-84C9-CE0375F2779F Q35191941-BF7C0814-689D-4AA6-993B-7EEF291C1C20 Q35217494-5E8B0991-5E3C-46F1-8261-883CEF0F8EA4 Q35341887-E5052AA3-8D29-48DF-8C5A-FDDA76544F85 Q35652068-23427D74-4DF2-491B-BE7F-9FF49D26F5A7 Q36122915-AD41728F-6ABA-4F76-8E98-7D3A23061BA3 Q36155940-E3C25AA1-2B95-42C5-BAA7-61698887E4F7 Q36478354-5A870367-B746-4097-BC41-2CC76E7FAA4B Q36483647-C374B2FB-51EC-4225-9554-48F2FFA0E0E1 Q36504794-AAED5261-7C45-47BD-A9DF-125AD5121367 Q36513949-F00BD899-7ADB-40B3-A004-A9305A33D28B Q36539063-1FF4FD7C-D279-48D6-98E3-58D55ED8EA90 Q36668524-D384D3DF-C5B2-4BF8-B49B-10D1E1C6827F Q36901955-8B81B10C-3B80-4FB0-B54B-8B602B318BAF Q37145046-D6710460-7CF9-467B-AC94-79A3D7C341F5 Q37416012-BAECAA19-6F6B-49DC-987E-45D772C91DEF

P2860

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

http://www.wikidata.org/entity/Q35978682

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@ast

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@en

type

label

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@ast

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@en

prefLabel

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@ast

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@en

P1433

Q35978682-EF57C0CA-9D65-4AD1-BB69-704D10B8D5BF

P1476

Q35978682-995F13DA-79DE-4A43-9F82-9EA8056903DB

P2093

Q35978682-1AB56AE2-F445-4CBF-8992-871E8CEAF8AB

Q35978682-51F1F73F-D297-4DC5-9060-3448EBEB2F69

Q35978682-60B60155-2827-4A60-8E6C-D4BC2CDF56B1

Q35978682-A83E46D1-1EDF-4B8F-82CF-58F30780D09A

Q35978682-E8CB2115-310B-4A11-88A3-D479A39044BD

P2860

Q35978682-036DFEC8-7860-4E16-9502-52FB68DCB89D

Q35978682-15568692-B6D3-4061-82F0-BC9A580DF34C

Q35978682-16C46EF4-9B13-443C-9047-152D4ACE657A

Q35978682-54E4BD67-B0C1-4611-A87B-B2B93BE52D5E

Q35978682-6BAAFAD7-3B01-4DEF-9039-AD46648C5152

Q35978682-75BF37D2-4EB4-4F2A-AFCC-8F97A60BD27D

Q35978682-7834FE0F-E94E-4C8F-9AEA-62F8E059E9A7

Q35978682-899F6B22-3FF3-42D8-8F56-0E1F914D059A

Q35978682-B2F29FF2-9C20-4ADE-A8E2-9DBDBC31DEA4

Q35978682-B8453915-1244-4BFA-BC03-E2A16AAC8768

P304

Q35978682-35A85779-BA14-4C1B-80EB-3E4EAB7E3399

P31

Q35978682-4FBCA19F-7076-4EC1-9910-DA495DC39571

P356

Q35978682-A58E7F2A-5DA9-4F94-BA9F-38CE4C78AB92

P407

Q35978682-30F711F7-770D-468E-9DEC-1844F8F25EEB

P433

Q35978682-A904414F-4C7D-4D44-9859-A770C017CA8F

P478

Q35978682-37B60B29-D835-401C-978B-75432107D11E

P50

Q35978682-1BCA5F8D-EE14-4B31-84B1-2E36F299BC80

P577

Q35978682-2CDE88AA-67F0-4976-8B02-F1F3C3D7C7AC

P5875

Q35978682-A489B523-2BEA-40D9-91E0-B988C150C4AD

P698

Q35978682-09FF31B3-A95C-4F10-8BCC-FE359A039D1D

P932

Q35978682-084FB9FF-4521-40EB-B322-F487AA6AC762

P356

PNAS.1834478100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

@en

P2093

Gi-Eun Rhie

http://www.w3.org/2001/XMLSchema#string

John J Mekalanos

http://www.w3.org/2001/XMLSchema#string

Julia Y Wang

http://www.w3.org/2001/XMLSchema#string

Michael H Roehrl

http://www.w3.org/2001/XMLSchema#string

Michael Mourez

http://www.w3.org/2001/XMLSchema#string

P2860

Anthrax as a biological weapon, 2002: updated recommendations for management

Identification of residues lining the anthrax protective antigen channel.

Designing a polyvalent inhibitor of anthrax toxin.

Stoichiometry of anthrax toxin complexes.

The capsule of bacillus anthracis, a review

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.

Development of an improved vaccine for anthrax

Structure and function of anthrax toxin.

P304

10925-10930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1834478100

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

R. John Collier

P577

2003-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10579275

http://www.w3.org/2001/XMLSchema#string

P698

12960361

http://www.w3.org/2001/XMLSchema#string

P932

196904

http://www.w3.org/2001/XMLSchema#string